MIRA
INFORM REPORT
|
Report Date : |
19.03.2008 |
IDENTIFICATION
DETAILS
|
Name : |
EMPROFAC
SARL |
|
|
|
|
Registered Office : |
Caixa Postal 59, Praia, Santiago |
|
|
|
|
Country : |
Cape Verde |
|
|
|
|
Date of Incorporation : |
14.06.1983 |
|
|
|
|
Com. Reg. No.: |
1316/83 Cape Verde |
|
|
|
|
Legal Form : |
Government Institution |
|
|
|
|
Line of Business : |
Import and Distribution of Pharmaceutical Drugs, also acts as national
pharmaceutical board for public health control, consumer protection and
regulatory functions |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 300,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
COMPANY REPORTED
EMPROFAC
SARL
Other Name
EMPRESA
NACIONAL DE PRODUTOS FARMACEUTICOS
Principal Address
Caixa Postal 59, Praia, Santiago, Cape Verde
Telephone: +238-2627895/ 615636
Fax: +238-2627899
Email: emprofac@cvtelecom.cv
Internet: None
Established
14/06/1983
Registration
No. 1316/83 Cape Verde
Legal Form
Government
Institution
Stock Listing
Not Listed
Workforce
2006
200
Office & Factories
Head offices Tira Chapeu, Zona Industrial, Praia,
Santiago, Cape Verde
Branches None
Company Profile
Paid in Capital CVE. 10,000,000
Subscribed Capital CVE. 10,000,000
Shareholders
Name Position Amount
Ratio
Mrs. Maria da Luz
Leite CEO
Mr. Jose R Fonseca Director
Government of Cape
Verde Shareholder 1.00%
Public
Shareholders Shareholder 99.00%
Total 100.00%
Credit Opinion
Our proposed credit amount of USD 300,000 is recommendable
Affiliated Companies
Company (1)
Management/ Directors
President/ CEO (1)
Name Mrs.
Maria da Luz Leite
Remarks Top
Decision Maker
Þ
Top decision maker is the person who has the ultimate authority or power
to make important managerial decisions. He/She may or may not be officially
registered as a president or an executive director.
Business Activities
Import and
Distribution of Pharmaceutical Drugs, also acts as national pharmaceutical
board for public health control, consumer protection and regulatory functions
Terms of payment
Buying
terms 100% in tenders
Selling terms 50% in cash, 50% on credit
Suppliers
Medicinal
Companies and distributors
Customers
Hospitals and medical
Companies
Recent Sales
CVE.
1,200,000,000
Exports
Neighboring
Islands
Export Ratio
30.0%
Import Ratio
60.0%
Domestic Market Share
10.0%
Banking relationship
Main Banks BCA Bank
Banco
Cabo-Verdiano de Negocios
Credit Check of Subject,
President & CEO (as of report date)
Payment Morale: In the documents at our
disposal nothing adverse has been shown so far.
CREDIT RATING: Financial situation is
average.
COMMENTS
Maximum credit we recommend is USD 300,000 outstanding at any one time.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)